Neurological examination and measurement of biomarkers should be part of a multimodal approach to neuroprognostication in a comatose post–cardiac arrest patient.
<h3>What is Neuroprognostication?</h3>
This is a medical procedure which is used to determine if a patient has poor neurologicalprognosis.
This is done through measurement of biomarkers such as neuron-specific enolase (NSE) and other examinations.
The objective statement would be choice B. Since objective statements describe exactly a point being made that’s not based on opinions in this case nor feelings.